That’s right, folks – a cool $480 million just rolled off the whales’ yachts as soon as XRP winked at $3. Cue the collective nervous twitch in the XRP crowd, because when these crypto whales start selling, it’s rarely a sign they’re planning a surprise party. More like, “Let’s party now, panic later.”
If this ascent materializes, Oracle will join a pantheon of digital oligarchs-Nvidia, Microsoft, Apple, and others-each a bureaucratic leviathan in the $2 trillion club. Broadcom and Meta Platforms, currently clinging to the periphery, require merely 16% more growth to complete this surreal tableau of excess. The S&P 500 now trembles under the weight of the “Ten Titans,” whose combined 39% share resembles a corporate coup disguised as market logic.
But let us not dwell too long on what might have been. The future, after all, is a realm where even the devil himself might take an interest in Johnson & Johnson’s quarterly earnings. For this colossus of pharmaceuticals and medical devices, with a market cap of $430 billion, is no mere automaton of industry. It is a creature of contradictions: a dividend aristocrat with a 2.9% yield, yet burdened by a legal specter that haunts it like a shadow at a ball. Its recent payout increases-63 consecutive years of them-suggest the resilience of a saint, while the talcum powder litigation looms like a Gothic cathedral of uncertainty.
Galaxy’s pile now towers at roughly 6.5 million SOL, the sum of $1.55 billion, safely ensconced in the vaults of Coinbase Prime-far from the claws of curious mortals.
Yet, lo and behold! This September, the index exhibits a rather improbable vitality; it has crested by 1.9% as of late. But, dear reader, let us not indulge in premature exultation; over two weeks yet remain, and with them lie the potent specters of wild fluctuations, either soaring higher on angel wings or plummeting earthward with a tragic grace. Hence, we are beckoned to ponder: Is it truly prudent to acquire stocks in this month of warm breezes and waning sun? Let us embark on this intellectual voyage.
So, here we are, just a few weeks ago, Verizon turned in results that caused the market to pause-did I hear “better than expected”? Well, yes. And just like that, they nudged their full-year outlook upwards. Investors can finally see a little more clearly the spectacle of balancing growth spending against shareholder returns. The question lingers though, like an awkward silence-is this juicy high yield an actual gift or just a mirage of a value trap?
This “CrypNuevo” fellow – sounds like a particularly spicy salsa – thinks this whole thing could trigger a rally. Altcoins, he says, are already doing… things. Gaining strength, apparently. Strength, like a toddler attempting to lift a barbell.
Some investors have tried to ride Buffett’s coattails, buying financial or consumer staples like a child clutching a security blanket. It worked, for a time. But now, even at 95-set to retire, never particularly tech-savvy-Buffett is betting on artificial intelligence. A man who once said, “Technology is like a loaded gun. You don’t know what to do with it,” now wagers $68 billion on two AI stocks. The universe is a comedy.
Deploying $35,000 across two Dividend Kings-Altria Group and Target-could theoretically yield $20,000 annually in dividends within a decade, contingent upon sustained earnings power and disciplined capital allocation. Below, we dissect the strategic rationale and operational dynamics underpinning this approach.
Energy demand? A fleeting dream. The world’s a fickle lover, and oil‘s not the only game in town anymore. But the article’s heroes-TotalEnergies, Chevron, Energy Transfer-these are not saviors. They’re relics in a dying empire, clutching at clean energy like a drunkard’s last bottle.